Optimax Holdings Stock

Equities

OPTIMAX

MYQ0222OO008

Healthcare Facilities & Services

End-of-day quote BURSA MALAYSIA 06:00:00 2024-04-23 pm EDT 5-day change 1st Jan Change
0.65 MYR +0.78% Intraday chart for Optimax Holdings +0.78% +4.00%
Sales 2023 114M 23.86M Sales 2024 * 126M 26.38M Capitalization 351M 73.55M
Net income 2023 12M 2.51M Net income 2024 * 15M 3.14M EV / Sales 2023 2.97 x
Net cash position 2023 1.01M 212K Net cash position 2024 * 9.7M 2.03M EV / Sales 2024 * 2.71 x
P/E ratio 2023
27.2 x
P/E ratio 2024 *
23.2 x
Employees -
Yield 2023
1.92%
Yield 2024 *
2.54%
Free-Float 25.39%
More Fundamentals * Assessed data
Dynamic Chart
Optimax Holdings Berhad Appoints Tan Lai Hong as Company Secretary CI
Optimax Holdings Berhad Announces the Resignation of Rebecca Kong Say Tsui as Company Secretary, Effective March 27, 2024 CI
Optimax Holdings Berhad Announces Interim Single-Tier Tax-Exempt Dividend for the Year Ended 31 December 2023, Payable on 01 April 2024 CI
Optimax Holdings Berhad Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Optimax Holdings Berhad Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Optimax Holdings Berhad Announces Interim Single-Tier Dividend, Payable on 29 December 2023 CI
Optimax Holdings Berhad Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Optimax Holdings Berhad Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Optimax Holdings Berhad Appoints Zaiton Binti Nasir as Independent and Non-Executive Member of Nomination and Remuneration Committee, Date of Change 1 September 2023 CI
Optimax Holdings Berhad Appoints Zaiton Binti Nasir as Independent and Non-Executive Director, Date of Change 1 September 2023 CI
Optimax Holdings Berhad Appoints Zaiton Binti Nasir as Independent and Non-Executive Member of Audit Committee, Date of Change 1 September 2023 CI
Optimax Secures Plastic Surgery Licence from Malaysian Health Ministry MT
Optimax Holdings Berhad Secures License to Offer Plastic Surgery and Ascastic Services CI
40,500,000 Ordinary Shares of Optimax Holdings Berhad are subject to a Lock-Up Agreement Ending on 6-AUG-2023. CI
Optimax Holdings Berhad Announces Retirement of Yap Eng Gee as Independent and Non Executive Member of Nomination and Remuneration Committee CI
More news
1 day+0.78%
1 week+0.78%
Current month-4.41%
1 month+0.78%
3 months+8.33%
6 months-1.52%
Current year+4.00%
More quotes
1 week
0.63
Extreme 0.63
0.66
1 month
0.63
Extreme 0.63
0.71
Current year
0.58
Extreme 0.58
0.71
1 year
0.58
Extreme 0.58
0.76
3 years
0.50
Extreme 0.4975
0.85
5 years
0.31
Extreme 0.305
0.94
10 years
0.31
Extreme 0.305
0.94
More quotes
Managers TitleAgeSince
Chief Executive Officer 36 19-11-30
Director of Finance/CFO 36 18-08-31
Chief Operating Officer - 20-12-31
Members of the board TitleAgeSince
Director/Board Member 79 -
Chairman 62 -
Director/Board Member 68 18-08-08
More insiders
Date Price Change Volume
24-04-24 0.65 +0.78% 325,500
24-04-23 0.645 +0.78% 303,000
24-04-22 0.64 0.00% 651,200
24-04-19 0.64 -2.29% 736,700
24-04-18 0.655 +1.55% 184,700

End-of-day quote BURSA MALAYSIA, April 23, 2024

More quotes
Optimax Holdings Berhad is a Malaysia-based investment holding company. The Company provides eye specialist services across Malaysia through a network of 17 eye specialist centers. Its centers provide a range of treatments aimed at addressing various eye and vision problems, including refractive errors, cataracts, glaucoma, macular degeneration, diabetic retinopathy, and other eye diseases and disorders. Its services are categorized into four groups: refractive surgery comprising of laser vision correction and implant vision correction; treatment of eye diseases and disorders including cataract surgery and other eye medical treatment; consultation and dispensary services comprising doctor consultation and medication, and oculoplastic surgery provides functional and cosmetic treatment for disorders around the eye. It also provides related services such as eye examinations performed by its in-house optometrists, sales of optical wear, vaccination as well as laboratory tests for patients.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.65 MYR
Average target price
0.85 MYR
Spread / Average Target
+30.77%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. OPTIMAX Stock